This inventor holds 1 USPTO granted patent. Top assignee: Idenix Pharmaceuticals, Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Alistar James Stewart in HCV Treatment
Introduction
Alistar James Stewart, based in Wayland, MA, is an accomplished inventor known for his significant contributions to the field of antiviral treatments. With a focus on Hepatitis C Virus (HCV) infections, Stewart's work at Idenix Pharmaceuticals, Inc. has led to important developments in the pharmaceutical industry.
Latest Patents
Stewart holds a patent for "Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of HCV." This innovative patent outlines compounds, compositions, and methods aimed at treating Flaviviridae infections, specifically HCV. The patent describes various formulations of nucleoside derivatives that can be administered alone or in combination with other antiviral agents, emphasizing their potential effectiveness in combatting viral infections. The compounds include novel 2'-cyano, azido, or amino nucleosides, along with their pharmaceutically acceptable forms.
Career Highlights
Throughout his career, Alistar James Stewart has demonstrated a commitment to advancing antiviral therapies. His work at Idenix Pharmaceuticals, Inc. has been pivotal in expanding the options available for treating HCV infections. His innovative approaches are a testament to his expertise and dedication to improving healthcare outcomes for patients facing viral challenges.
Collaborations
Stewart collaborates with esteemed colleagues like David Dukhan and Christophe Parsy. Together, they contribute to the dynamic research environment at Idenix Pharmaceuticals, working towards the development of cutting-edge antiviral treatments and enhancing the understanding of virus interactions within the human body.
Conclusion
Alistar James Stewart's contributions to the field of antiviral medicine are invaluable, particularly in the context of HCV treatment. Through his research and innovation, he continues to shape the future of pharmaceutical solutions aimed at combating viral infections, making a lasting impact on public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile